Aristotle Capital Boston Reduces Holdings in QuidelOrtho

Summary

Aristotle Capital Boston reduced its holdings in QuidelOrtho by 9.5% in the fourth quarter, now holding 312,640 shares valued at approximately $13.93 million. Other hedge funds also adjusted their positions in the company. Analysts have mixed ratings for QuidelOrtho, generally rating it as ‘Hold’ with an average target price of $46.83. The stock opened at $29.12, with a 52-week price range from $23.77 to $49.45. QuidelOrtho reported earnings per share of $0.63, below expectations of $0.44.Market Beat

Impact Analysis

The reduction in holdings by Aristotle Capital Boston indicates a cautious stance toward QuidelOrtho, reflecting concerns over its recent earnings performance, which fell short of expectations. First-order effects include potential downward pressure on the stock price due to reduced investor confidence. Analysts have mixed opinions, with some rating the stock as ‘Hold’ and adjusting target prices, reflecting uncertainty about the company’s growth prospects.Market Beat+ 3 Second-order effects could see similar actions from other investors in the same industry, impacting overall market sentiment and stock volatility. Opportunities for investors may arise in options strategies such as protective puts to hedge against further declines or potential rebounds if corrective measures improve earnings performance. Risks involve continued underperformance affecting long-term investment returns and increased competitive pressure.Market Beat+ 3